company? Let’s change
that.
Don't see your company?
Create a company profileGT Molecular was created to develop new molecular detection technology for cancer research and harmful pathogen detection. We have recently focused these powerful tools on the detection of SARS-CoV-2 in wastewater to support communities around the country with their monitoring programs. Ultrasensitive Molecular Assays, Digital PCR and qPCR Tests End-to-End solutions for cancer detection and waterborne pathogens including SARS-CoV-2. Detect as little as 1-3 molecules of target DNA
By harnessing the power of genetics and technology, Invitae’s (“in-VEE-tay”) mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. We have helped improve care for hundreds of thousands of patients and their providers by driving down the cost of reliable, comprehensive, and actionable genetic testing. Our platform provides genetic information for use throughout medicine—and throughout life.
Zynex Monitoring Solutions "ZMS" is a engineering and I.T. branch of Zynex, Inc. (NASDAQ: ZYXI). We invent, research, and engineer non-invasive medical device solutions for monitoring physiological changes. Our premiere FDA-approved product - The Zynex Monitoring System (CM-1500) - is an innovative, non-invasive monitoring device, designed to monitor relative fluid volume changes.
Enrich is the leader in biotech and pharmaceutical portfolio management software, used in over half of the top 10 life sciences companies to value and manage portfolios of high risk, high investment assets. Our proprietary suite of tailored analytics and flexible on-demand visualizations are ideally suited for portfolio management.
AOA Dx is developing the next frontier in early-stage cancer detection through its pioneering work in glycolipids and proprietary biomarker technology. Our revolutionary tumor marker ganglioside platform, GlycoLocate™, is paving the way for life-saving early cancer detection. In a first of its kind, AOA Dx has developed AKRIVIS GD™, an early-stage liquid biopsy test for ovarian cancer, that has proven excellent sensitivity and specificity in a recent study. We foresee novel tumor biomarker gangliosides as the future for diagnosis, prognosis, monitoring, and eventually targeted therapies across multiple cancers. AOA Dx was co-founded by three experts and passionate advocates of women’s health, who have worked together at two previous diagnostic startups, that both resulted in successful exits upon commercialization.
Amerita, Inc. is a specialty infusion company focused on providing complex pharmaceutical products and clinical services to patients outside of the hospital. This market is expanding rapidly and is driven by increasing healthcare costs that are moving patients into the most cost-effective delivery settings, a growing bio-pharmaceutical pipeline of
Every company seeks to build higher engagement with their customers online, yet they have little-to-no insight on how their customers’ brains actually work, what’s most meaningful to them, what their subconscious desires are when making a sale, ideal purchasing moods, or much less, how to truly create a biological change within their neurobiology to increase engagement, sales, and retention. We fill this gap by integrating our full-service team of trained neuromarketing experts, brand creators, web designers, copywriters, web, and software developers to create a whole new level of user experience called “Neural Experience” or "NX" for short. Contact us to learn how NX can grow your business online.
At Flagship, we are dedicated to improving the health and safety of patients everywhere by pioneering the most advanced tissue image analysis, clinical support, and diagnostics services that help pharmaceutical companies develop the solutions to treat, manage, and cure the world’s most challenging medical conditions.
Our team is made up of former accountants, financial professionals, and IT executives. We seek to hire team members who already have a deep knowledge of the industries they serve to ensure the success of our placements – because of this we stand by each placement with a guarantee. Whether you’re looking to hire an executive, one specialized candidate or hundreds of temporary employees, our unique expertise and proven recruitment process helps uncover hidden talent to enhance your team at every level. You have options when it comes to selecting a recruiting partner. We get it. 3-Point Recruiting was born out of a vision to redefine the recruiting process, so we do things a little differently. Our entire team has real-world experience in the industries they serve, bringing honesty, integrity, and proven success to each opportunity.
The Sequencing Center, a next generation genome sequencing company, offers affordable genome sequencing, bioinformatics, and genome data management for research, pharmaceutical, and clinical organizations. Our services are designed for organizations performing research on bacterial, viral, and human-oriented projects.
msGenomics, Inc. (SKINDROID) is a medical technology company leveraging proprietary analytical systems to offer clinical lab testing services to personal wellness-oriented consumers, health consumers (patients), healthcare providers, and pharmaceutical companies.
Front Range Biosciences is a value-driven agricultural biotech company with the mission to improve society by applying science to high-value crops. Our goal is to become a trusted global leader in agricultural technology, coffee, and hemp products using our innovative Clean Stock nurseries, quality breeding programs, and contemporary seed testing.
The SmartTab technology platform is a personalized wireless drug delivery solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is focused on the development of three drug delivery systems: TargetTab™, InjectTab™ and MultiTab™. Providing novel effective therapies to improve patient outcomes and compliance.
Work Your Passion. Live Your Purpose.